FRNM
Freenome, Inc. Common stock
NASDAQ · Financial Services · Financial - Conglomerates · US
$12.57
+6.98%Oct 11, 2026, 17:00 UTC
FRNM announced that it will present validation data on an updated version of its SimpleScreen CRC blood-based screening test at the ACG 2026 Annual Meeting in Nashville.
Source: